Auchenflower, Australia

Carol Wicking

Average Co-Inventor Count = 22.0

ph-index = 1

Forward Citations = 11(Granted Patents)

Forward Citations (Not Self Cited) = 11(Sep 21, 2024)


Years Active: 2003-2008

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: The Innovative Contributions of Carol Wicking in Tumor Suppressor Research

Introduction: Carol Wicking, an accomplished inventor based in Auchenflower, Australia, has made significant strides in the field of cancer research through her patented inventions. With a total of two patents to her name, Wicking has focused her efforts on the genetics of basal cell carcinoma, providing critical insights into tumor suppression mechanisms.

Latest Patents: Wicking's latest inventions include the following patents:

1. **Basal Cell Carcinoma Tumor Suppressor Protein**: This invention delineates the role of a tumor suppressor gene, with its inactivation being a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. The NBCCS gene is identified as a homologue of the patched (ptc) gene, highlighting its importance in cancer development.

2. **Basal Cell Carcinoma Tumor Suppressor Gene**: Similar to her first patent, this invention also addresses the tumor suppressor gene's inactivation, reinforcing its significance in the pathology of nevoid basal cell carcinoma syndrome and sporadic basal cell carcinomas. The connection to the NBCCS gene and the patched (ptc) gene further emphasizes the complexity of tumor suppression.

Career Highlights: Carol Wicking has dedicated her career to unraveling the genetic underpinnings of cancer. Her position at the United States of America as represented by the Secretary of the Department of Health and Human Services showcases her involvement in high-impact research and innovation in health sciences. Her contributions are paving the way for better understanding and treatment of basal cell carcinomas.

Collaborations: Throughout her career, Wicking has collaborated with notable scientists, including Michael C. Dean and Heidi Eve Hahn. These partnerships reflect her commitment to interdisciplinary research, which is vital for advancing knowledge and discovering new therapeutic avenues in cancer treatment.

Conclusion: Carol Wicking stands out as a key inventor in tumor suppressor research. Her innovative patents not only offer insights into the genetic factors influencing basal cell carcinoma but also contribute to the broader field of cancer genetics. As she continues her work, the scientific community looks forward to the potential advancements her inventions may bring in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…